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A 48 year old man presented to his general practitioner with a 12 month history of fatigue (which he put down to long office hours) and with urinary frequency. He had no previous health problems, his blood pressure was 145/85 mm Hg, and his body mass index was 29. His father had developed type 2 diabetes at the age of 65 years, and his paternal grandmother had been found to have diabetes at the age of about 60 following the development of a gangrenous toe. The patient's dipstick urine test showed no glycosuria, ketonuria, proteinuria, blood, leucocytes, or nitrites.
What is the next investigation?
All the possible causes of fatigue should be considered, 1 but given the patient's symptoms and his risk factors for developing type 2 diabetes, including family history and being overweight, a diagnosis of diabetes certainly needs to be excluded. Tests for diabetes are used to evaluate both patients with symptoms (as in this case) and asymptomatic patients who have been identified by a validated risk assessment tool as being at high risk of developing type 2 diabetes. 
Using glucose to diagnose diabetes
Since the early 20th century, the diagnosis of diabetes has been based on the measurement of glucose concentrations in the blood. This usually takes the form of laboratory measured fasting plasma glucose concentration and, when indicated, a glucose concentration two hours after an oral glucose load. However, "random" (post-prandial) measurement can suffice if it is unequivocally raised, especially in a patient with symptoms. The diagnostic threshold concentrations for glucose in use by the World Health Organization are defined as those above which it is known that a person will be at high risk of developing, if they are not already present, the microvascular complications of diabetes, particularly retinopathy. 3 In non-pregnant adults, the main indication for an oral glucose tolerance test is when the fasting plasma glucose concentration lies between the values suggestive of normality and overt diabetes-namely, in the impaired fasting glucose range of 6.1-6.9 mmol/L inclusive. The two hour post-glucose load measurement can then help to distinguish patients who have solely impaired fasting glucose from those who have both impaired fasting glucose and impaired glucose tolerance (plasma glucose concentration 7.8 to <11.1 mmol/L) and from those who can be diagnosed as having diabetes purely on the basis of their two hour glucose result being 11.1 mmol/L or above (box 1).
Using haemoglobin A 1c to diagnose type 2 diabetes
As can be seen, measuring glucose in the blood to diagnose diabetes can be inconvenient for patients, as they are usually required to fast overnight; if an oral glucose tolerance test is needed, the procedure is laborious, time consuming, and costly. For this reason, in recent years, more consideration has been given to whether measurement of glycated haemoglobin-haemoglobin A 1c (HbA 1c )-might be a valid alternative to glucose as a diagnostic test for diabetes, although this concept has led to controversy. 4 Quite apart from not requiring a patient to fast overnight, HbA 1c measurement has several other potential advantages over glucose (box 2), including its property of giving an indication of glycaemia over several preceding weeks rather than at a single time point and, partly as a consequence, reduced day to day variation within an individual compared with glucose. 5 Advances in the global standardisation of HbA 1c measurement culminated in WHO publishing advice in 2011 that recommends an HbA 1c threshold of 48 mmol/mol (6.5%) or above for the 6 Since then, an expert committee in the United Kingdom, which included seven clinical professional bodies and National Health Service organisations, came to a consensus recommending that a diagnosis of diabetes should be made only after a confirmed raised HbA 1c value. The committee also introduced a new category of patients who are judged as being at high risk of developing diabetes solely on the basis of an HbA 1c value of 42-47 mmol/mol (6.0-6.4%) (figure⇓). 
When not to use HbA 1c to diagnose diabetes
One of the main advantages of HbA 1c -that it can give an indication of previous glycaemia-is also a disadvantage when hyperglycaemia could have developed rapidly, as rises in HbA 1c will lag behind those of glucose. This is why the test is unsuitable in clinical situations such as suspected type 1 diabetes, as well as many of the others described in box 3. Also, most laboratories are able to analyse glucose much more rapidly than HbA 1c , so requesting HbA 1c could introduce delay in an acute situation. In kidney failure (chronic kidney disease stage 5), the picture is complicated by patients often having a combination of haemolytic, iron deficiency, and chronic inflammation anaemias as well as forming urea derived carbamylated HbA 1c , which can also affect some HbA 1c analyses. Several treatments for HIV are also known to influence the HbA 1c value independently of glycaemia. Measurement of HbA 1c is not recommended when determining whether a pregnant woman has gestational diabetes, as it seems to be a poorer predictor of adverse fetal outcome than is glucose. 8 
Other cautions with using HbA 1c
Although HbA 1c should not be used in the situations already described, caution must also be exercised when using HbA 1c in the presence of an abnormal haemoglobin or in conditions that may affect red cell survival (box 3). 7 For example, haemoglobin E will form HbE 1c instead of HbA 1c , which may lead to an incorrect assessment of HbA 1c depending on the particular measurement method used by the local laboratory. Haemolytic anaemia can cause low HbA 1c values compared with glucose measurements, and iron deficiency anaemia can cause a raised HbA 1c , although how much influence iron deficiency might have at the diagnostic threshold is not yet clear. After a splenectomy, the lifespan of red blood cells is often increased and so could lead to HbA 1c values that are higher than would be anticipated for the level of glycaemia. The diagnosis of type 2 diabetes can be made on the basis of either HbA 1c or blood glucose criteria being met. However, these will not identify an identical population of people, as they are not completely concordant with one another. 4 For this reason, UK recommendations advise that only one or other test is used to follow the same patient and not a mixture of the two. So if HbA 1c shows a patient to be at high risk of diabetes, he or she should be followed up using the same test rather than blood glucose also being measured at the same time or later. The exception is if HbA 1c measurement is initially or subsequently identified as being inappropriate for that person, in which case a change to glucose measurement is warranted.
Laboratory or point of care measurement?
Several instruments for rapid point of care testing of HbA 1c are available for the monitoring of patients known to have diabetes, but most of these analysers do not perform sufficiently well to be used for diagnostic purposes. 9 If they are used, the analytical quality needs to be able to match that of clinical laboratories. 6 
Outcome
This patient had his HbA 1c measured and found to be 44 mmol/mol (6.2%). As this placed him into the category of being at increased risk of diabetes, he was given lifestyle and dietetic advice and had an assessment of other cardiovascular risk factors. He was asked to report any worsening in his symptoms of diabetes should this happen before the annual HbA 1c measurements now planned. 
